Xconomy’s San Francisco Biotech: The Next Generation

San Francisco


6:00pm - 8:45pm

Take a peek at biotech's next generation of leaders, ideas, and strategies through the stories of speakers from three pioneering biotechs that are pushing the status quo:

- Cortexyme is planning Phase 2 trials next year with a new Alzheimer's approach: blocking brain bacteria it believes are responsible for cognitive decline.

- Allogene Therapeutics' founders, previously at Kite Pharma, are advancing a different kind of CAR-T to fight cancer.

- RDMD just launched and is building a health-data repository for rare diseases to help design diagnostics and clinical trials.

CLSA Members receive $25 discount! Please email to learn more.

Click Here for More Information

Contact: Nate Leskovic
Contact Email:

Event Address:

Byers Auditorium
Genentech Hall at UCSF Mission Bay
600 16th Street
San Francisco, CA 94158